Literature DB >> 11412865

REM sleep behavior disorder in sleep-disordered patients with versus without Parkinson's disease: is there a need for polysomnography?

I Eisensehr1, H v Lindeiner, M Jäger, S Noachtar.   

Abstract

We reviewed the polysomnograms (PSGs) of 292 consecutive patients with sleep disorders (Parkinson's disease (PD), n=19, other sleep disorders, n=273) to investigate the sensitivity and specificity of the clinical diagnosis of rapid eye movement behavior disorder (RBD) compared with polysomnographic diagnosis. Patients with dementia, multiple system atrophy, or any other neurodegenerative disease were excluded. RBD was diagnosed clinically if the minimal criteria, according to the guidelines given in the International Sleep Disorders Classification, were fulfilled. The following PSG criteria were required for diagnosis of RBD: REM sleep without muscle atonia seen in PSG associated with motor behavior visible in the PSG-synchronized videotape. Nine of nineteen PD patients (47%) had RBD. RBD occurred in only four patients without PD (1.8%). The sensitivity of specialized interviews for identifying RBD clinically was good in non-PD patients (sensitivity: 100%, specificity: 99.6%). However, the sensitivity was poor (33%) with a specificity of 90%, in patients with PD. We conclude that the diagnosis of RBD in patients with PD requires PSG, whereas interviews are sufficient for diagnosing RBD in non-PD patients.

Entities:  

Mesh:

Year:  2001        PMID: 11412865     DOI: 10.1016/s0022-510x(01)00480-4

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  34 in total

Review 1.  Diagnostic tools for REM sleep behavior disorder.

Authors:  Ariel B Neikrug; Sonia Ancoli-Israel
Journal:  Sleep Med Rev       Date:  2011-12-14       Impact factor: 11.609

2.  Clinical correlates of periodic limb movements in sleep in Parkinson's disease.

Authors:  Naima Covassin; Ariel B Neikrug; Lianqi Liu; Jody Corey-Bloom; Jose S Loredo; Barton W Palmer; Jeanne Maglione; Sonia Ancoli-Israel
Journal:  J Neurol Sci       Date:  2012-01-25       Impact factor: 3.181

3.  Sleep disorders and daytime sleepiness in Parkinson's disease.

Authors:  Renee Monderer; Michael Thorpy
Journal:  Curr Neurol Neurosci Rep       Date:  2009-03       Impact factor: 5.081

Review 4.  Sleep disorders in multiple system atrophy.

Authors:  I Ghorayeb; B Bioulac; F Tison
Journal:  J Neural Transm (Vienna)       Date:  2005-08-05       Impact factor: 3.575

5.  Parkinson's disease and REM sleep behavior disorder result in increased non-motor symptoms.

Authors:  Ariel B Neikrug; Julie A Avanzino; Lianqi Liu; Jeanne E Maglione; Loki Natarajan; Jody Corey-Bloom; Barton W Palmer; Jose S Loredo; Sonia Ancoli-Israel
Journal:  Sleep Med       Date:  2014-05-10       Impact factor: 3.492

Review 6.  Parkinson disease: an update.

Authors:  Steven J Frucht
Journal:  Neurologist       Date:  2004-07       Impact factor: 1.398

Review 7.  Excessive daytime sleepiness and sleep disturbances in patients with neurological diseases: epidemiology and management.

Authors:  Svenja Happe
Journal:  Drugs       Date:  2003       Impact factor: 9.546

8.  The REM Sleep Behavior Disorder Screening Questionnaire: Validation Study of the Korean Version (RBDQ-KR).

Authors:  Sooyeoun You; Hye-Jin Moon; So Young Do; Yun-Kwok Wing; Jun-Sang Sunwoo; Ki-Young Jung; Yong Won Cho
Journal:  J Clin Sleep Med       Date:  2017-12-15       Impact factor: 4.062

9.  REM sleep behavior disorder in Parkinson's disease: a questionnaire-based survey.

Authors:  Rositsa Poryazova; Michael Oberholzer; Christian R Baumann; Claudio L Bassetti
Journal:  J Clin Sleep Med       Date:  2013-01-15       Impact factor: 4.062

10.  Effects of sleep disorders on the non-motor symptoms of Parkinson disease.

Authors:  Ariel B Neikrug; Jeanne E Maglione; Lianqi Liu; Loki Natarajan; Julie A Avanzino; Jody Corey-Bloom; Barton W Palmer; Jose S Loredo; Sonia Ancoli-Israel
Journal:  J Clin Sleep Med       Date:  2013-11-15       Impact factor: 4.062

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.